Literature DB >> 21309706

Incidence and predictors of acute kidney injury in an urban cohort of subjects with HIV and hepatitis C virus coinfection.

Shikha Garg1, Melanie Hoenig, Erika M Edwards, Caleb Bliss, Timothy Heeren, Sheila Tumilty, Alexander Y Walley, Margaret J Koziel, Paul R Skolnik, C Robert Horsburgh, Deborah Cotton.   

Abstract

Coinfection with hepatitis C (HCV) significantly increases the risk of acute and chronic renal disease in HIV-infected individuals. However, the burden of acute kidney injury (AKI) directly attributable to HIV among HCV-infected individuals and associated risk factors are not well understood. Within a prospective cohort, AKI episodes were identified by a rise in creatinine of 0.5 mg/dL. Incidence of first AKI events was calculated for HIV/HCV coinfected versus HCV monoinfected subjects, and multivariable analyses using Cox proportional hazards were performed to identify predictors of AKI. Throughout the study period, 35% HIV/HCV coinfected and 17% HCV monoinfected subjects developed AKI, with incidence of 8.74/100 person-years and 3.53/100 person-years, respectively (hazard ratio (HR) 2.48; [95% confidence interval (CI) 1.50, 3.74]). In multivariable analysis, HIV coinfection (HR 2.19 [1.33, 3.62]), decompensated cirrhosis (HR 6.64 [3.81, 11.6]), and cocaine use (HR 2.06 [1.15, 3.71]) were independently associated with AKI. HCV genotype, HCV viral load, hazardous drinking, and heroin use were not associated with AKI. Study limitations included potential misclassification bias of HCV-infected individuals as serial HIV antibody testing was not routinely performed after study entry, and inability to adjust for tenofovir use in multivariable analysis. In conclusion, among subjects with HCV infection, decompensated cirrhosis, HIV coinfection, and cocaine use are associated with increased risk of AKI. These findings highlight the importance of preventing and treating cirrhosis, controlling HIV coinfection, and reducing cocaine use in HIV/HCV coinfected persons.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21309706      PMCID: PMC3101898          DOI: 10.1089/apc.2010.0104

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.078


  28 in total

1.  Fanconi syndrome and renal failure induced by tenofovir: a first case report.

Authors:  David Verhelst; Matthieu Monge; Jean-Luc Meynard; Bruno Fouqueray; Béatrice Mougenot; Pierre-Marie Girard; Pierre Ronco; Jerome Rossert
Journal:  Am J Kidney Dis       Date:  2002-12       Impact factor: 8.860

2.  Immunosuppression, hepatitis C infection, and acute renal failure in HIV-infected patients.

Authors:  Nora Franceschini; Sonia Napravnik; William F Finn; Lynda A Szczech; Joseph J Eron
Journal:  J Acquir Immune Defic Syndr       Date:  2006-07       Impact factor: 3.731

3.  Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America.

Authors:  Samir K Gupta; Joseph A Eustace; Jonathan A Winston; Ivy I Boydstun; Tejinder S Ahuja; Rudolph A Rodriguez; Karen T Tashima; Michelle Roland; Nora Franceschini; Frank J Palella; Jeffrey L Lennox; Paul E Klotman; Sharon A Nachman; Stephen D Hall; Lynda A Szczech
Journal:  Clin Infect Dis       Date:  2005-04-22       Impact factor: 9.079

4.  Relationship between hepatitis C and chronic kidney disease: results from the Third National Health and Nutrition Examination Survey.

Authors:  Judith I Tsui; Eric Vittinghoff; Michael G Shlipak; Ann M O'Hare
Journal:  J Am Soc Nephrol       Date:  2006-03-08       Impact factor: 10.121

5.  Predictors of proteinuria and renal failure among women with HIV infection.

Authors:  Lynda Anne Szczech; Stephen J Gange; Charles van der Horst; John A Bartlett; Mary Young; Mardge H Cohen; Kathryn Anastos; Preston S Klassen; Laura P Svetkey
Journal:  Kidney Int       Date:  2002-01       Impact factor: 10.612

6.  Incidence and etiology of acute renal failure among ambulatory HIV-infected patients.

Authors:  Nora Franceschini; Sonia Napravnik; Joseph J Eron; Lynda A Szczech; William F Finn
Journal:  Kidney Int       Date:  2005-04       Impact factor: 10.612

7.  Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study.

Authors:  Rainer Weber; Caroline A Sabin; Nina Friis-Møller; Peter Reiss; Wafaa M El-Sadr; Ole Kirk; Francois Dabis; Matthew G Law; Christian Pradier; Stephane De Wit; Börje Akerlund; Gonzalo Calvo; Antonella d'Arminio Monforte; Martin Rickenbach; Bruno Ledergerber; Andrew N Phillips; Jens D Lundgren
Journal:  Arch Intern Med       Date:  2006 Aug 14-28

Review 8.  An overview of non-cardiac cocaine toxicity.

Authors:  Jonathan Glauser; John R Queen
Journal:  J Emerg Med       Date:  2007-01-22       Impact factor: 1.484

9.  Acute renal failure in hospitalized patients with HIV: risk factors and impact on in-hospital mortality.

Authors:  Christina M Wyatt; Raymond R Arons; Paul E Klotman; Mary E Klotman
Journal:  AIDS       Date:  2006-02-28       Impact factor: 4.177

10.  Acute renal failure in critically ill HIV-infected patients.

Authors:  José António Lopes; Joana Fernandes; Sofia Jorge; José Neves; Francisco Antunes; Mateus Martins Prata
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

View more
  15 in total

1.  Dialysis-requiring acute kidney injury among hospitalized adults with documented hepatitis C Virus infection: a nationwide inpatient sample analysis.

Authors:  G N Nadkarni; A Patel; P K Simoes; R Yacoub; N Annapureddy; S Kamat; I Konstantinidis; P Perumalswami; A Branch; S G Coca; C M Wyatt
Journal:  J Viral Hepat       Date:  2015-07-20       Impact factor: 3.728

Review 2.  Hepatitis C Virus Infection Increases the Risk of Developing Chronic Kidney Disease: A Systematic Review and Meta-Analysis.

Authors:  Fabrizio Fabrizi; Simona Verdesca; Piergiorgio Messa; Paul Martin
Journal:  Dig Dis Sci       Date:  2015-07-21       Impact factor: 3.199

3.  Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN).

Authors:  Roberto Minutolo; Alessio Aghemo; Antonio Chirianni; Fabrizio Fabrizi; Loreto Gesualdo; Edoardo G Giannini; Paolo Maggi; Vincenzo Montinaro; Ernesto Paoletti; Marcello Persico; Francesco Perticone; Salvatore Petta; Massimo Puoti; Giovanni Raimondo; Maria Rendina; Anna Linda Zignego
Journal:  Infection       Date:  2018-09-25       Impact factor: 3.553

4.  Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN).

Authors:  Roberto Minutolo; Alessio Aghemo; Antonio Chirianni; Fabrizio Fabrizi; Loreto Gesualdo; Edoardo G Giannini; Paolo Maggi; Vincenzo Montinaro; Ernesto Paoletti; Marcello Persico; Francesco Perticone; Salvatore Petta; Massimo Puoti; Giovanni Raimondo; Maria Rendina; Anna Linda Zignego
Journal:  J Nephrol       Date:  2018-09-25       Impact factor: 3.902

5.  Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN).

Authors:  Roberto Minutolo; Alessio Aghemo; Antonio Chirianni; Fabrizio Fabrizi; Loreto Gesualdo; Edoardo G Giannini; Paolo Maggi; Vincenzo Montinaro; Ernesto Paoletti; Marcello Persico; Francesco Perticone; Salvatore Petta; Massimo Puoti; Giovanni Raimondo; Maria Rendina; Anna Linda Zignego
Journal:  Intern Emerg Med       Date:  2018-09-25       Impact factor: 3.397

6.  Survival in HIV-positive transplant recipients compared with transplant candidates and with HIV-negative controls.

Authors:  Michelle E Roland; Burc Barin; Shirish Huprikar; Barbara Murphy; Douglas W Hanto; Emily Blumberg; Kim Olthoff; David Simon; William D Hardy; George Beatty; Peter G Stock
Journal:  AIDS       Date:  2016-01-28       Impact factor: 4.177

7.  CD4 recovery on antiretroviral therapy is associated with decreased progression to liver disease among hepatitis C virus-infected injecting drug users.

Authors:  Jeffrey P Anderson; C Robert Horsburgh; Paige L Williams; Eric J Tchetgen Tchetgen; David Nunes; Deborah Cotton; George R Seage
Journal:  Open Forum Infect Dis       Date:  2015-02-28       Impact factor: 3.835

8.  Frequent injection cocaine use increases the risk of renal impairment among hepatitis C and HIV coinfected patients.

Authors:  Carmine Rossi; Joseph Cox; Curtis Cooper; Valérie Martel-Laferrière; Sharon Walmsley; John Gill; Ruth Sapir-Pichhadze; Erica E M Moodie; Marina B Klein
Journal:  AIDS       Date:  2016-06-01       Impact factor: 4.177

Review 9.  HIV and kidney diseases: 35 years of history and consequences.

Authors:  Pedro Campos; Alberto Ortiz; Karina Soto
Journal:  Clin Kidney J       Date:  2016-10-25

Review 10.  Systematic review of nephrotoxicity of drugs of abuse, 2005-2016.

Authors:  Kanaan Mansoor; Murad Kheetan; Saba Shahnawaz; Anna P Shapiro; Eva Patton-Tackett; Larry Dial; Gary Rankin; Prasanna Santhanam; Antonios H Tzamaloukas; Tibor Nadasdy; Joseph I Shapiro; Zeid J Khitan
Journal:  BMC Nephrol       Date:  2017-12-29       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.